These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 12673678

  • 1. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H, De Krijger RR, van der Harst E, Abbou M, IJzendoorn Y, Komminoth P, Dinjens WN.
    Int J Cancer; 2003 Jun 10; 105(2):190-5. PubMed ID: 12673678
    [Abstract] [Full Text] [Related]

  • 2. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
    Bender BU, Gutsche M, Gläsker S, Müller B, Kirste G, Eng C, Neumann HP.
    J Clin Endocrinol Metab; 2000 Dec 10; 85(12):4568-74. PubMed ID: 11134110
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bilateral pheochromocytomas and congenital anomalies associated with a de novo germline mutation in the von Hippel-Lindau gene.
    Assadi F, Brackbill EL.
    Am J Kidney Dis; 2003 Jan 10; 41(1):E3. PubMed ID: 12500216
    [Abstract] [Full Text] [Related]

  • 6. Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas.
    Gergics P, Patocs A, Toth M, Igaz P, Szucs N, Liko I, Fazakas F, Szabo I, Kovacs B, Glaz E, Racz K.
    Eur J Endocrinol; 2009 Sep 10; 161(3):495-502. PubMed ID: 19574279
    [Abstract] [Full Text] [Related]

  • 7. Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.
    Koch CA, Huang SC, Zhuang Z, Stolle C, Azumi N, Chrousos GP, Vortmeyer AO, Pacak K.
    Oncogene; 2002 Jan 17; 21(3):479-82. PubMed ID: 11821960
    [Abstract] [Full Text] [Related]

  • 8. Genotype-phenotype correlation in von Hippel-Lindau syndrome.
    Friedrich CA.
    Hum Mol Genet; 2001 Apr 17; 10(7):763-7. PubMed ID: 11257110
    [Abstract] [Full Text] [Related]

  • 9. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene.
    Brauch H, Hoeppner W, Jähnig H, Wöhl T, Engelhardt D, Spelsberg F, Ritter MM.
    J Clin Endocrinol Metab; 1997 Dec 17; 82(12):4101-4. PubMed ID: 9398721
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC, Prowse AH, Affara NA, Buys CH, Maher ER.
    Genes Chromosomes Cancer; 1998 Jul 17; 22(3):200-9. PubMed ID: 9624531
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M, da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU, Houlston RS, Richards FM, Latif F, Maher ER.
    Cancer Res; 2002 Jul 01; 62(13):3803-11. PubMed ID: 12097293
    [Abstract] [Full Text] [Related]

  • 14. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
    Maher ER, Webster AR, Richards FM, Green JS, Crossey PA, Payne SJ, Moore AT.
    J Med Genet; 1996 Apr 01; 33(4):328-32. PubMed ID: 8730290
    [Abstract] [Full Text] [Related]

  • 15. Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene.
    Cybulski C, Krzystolik K, Murgia A, Górski B, Debniak T, Jakubowska A, Martella M, Kurzawski G, Prost M, Kojder I, Limon J, Nowacki P, Sagan L, Białas B, Kałuza J, Zdunek M, Omulecka A, Jaskólski D, Kostyk E, Koraszewska-Matuszewska B, Haus O, Janiszewska H, Pecold K, Starzycka M, Słomski R, Cwirko M, Sikorski A, Gliniewicz B, Cyryłowski L, Fiszer-Maliszewska Ł, Gronwald J, Tołoczko-Grabarek A, Zajaczek S, Lubiński J.
    J Med Genet; 2002 Jul 01; 39(7):E38. PubMed ID: 12114495
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
    Prowse AH, Webster AR, Richards FM, Richard S, Olschwang S, Resche F, Affara NA, Maher ER.
    Am J Hum Genet; 1997 Apr 01; 60(4):765-71. PubMed ID: 9106522
    [Abstract] [Full Text] [Related]

  • 18. Von Hippel-Lindau syndrome. A pleomorphic condition.
    Friedrich CA.
    Cancer; 1999 Dec 01; 86(11 Suppl):2478-82. PubMed ID: 10630173
    [Abstract] [Full Text] [Related]

  • 19. Somatic mosaicism in von Hippel-Lindau Disease.
    Murgia A, Martella M, Vinanzi C, Polli R, Perilongo G, Opocher G.
    Hum Mutat; 2000 Jan 01; 15(1):114. PubMed ID: 10612832
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.